XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Equity (Tables)
3 Months Ended
Mar. 31, 2023
Equity  
Schedule of dividends declared by the Company (on a per share basis)

Common Stock

Preferred Stock

Dividend

Declaration Date

    

Dividend

    

Declaration Date

    

Series D

    

Series E

    

Series F

February 15, 2023

$

0.40

January 3, 2023

$

0.3984375

$

0.390625

$

0.390625

March 31, 2023

$

0.3984375

$

0.390625

$

0.390625

Schedule of reconciliation of the numerator and denominator of the basic and diluted EPS computations

A reconciliation of the numerator and denominator of our basic and diluted EPS computations is as follows ($ in thousands, except share and per share data):

Three Months Ended March 31, 

2023

2022

    

Basic

    

Diluted

    

Basic

    

Diluted

Net income attributable to common stockholders (1)

$

84,319

$

84,319

$

64,057

$

64,057

Net income attributable to noncontrolling interest (2)

7,585

6,816

Interest expense on convertible notes

6,081

3,995

Net income attributable to common stockholders and noncontrolling interest

$

84,319

$

97,985

$

64,057

$

74,868

Weighted average shares outstanding

181,116,674

 

181,116,674

 

153,420,238

 

153,420,238

Dilutive effect of OP Units (2)

 

16,293,589

16,325,095

Dilutive effect of convertible notes

17,230,358

15,111,154

Dilutive effect of restricted stock units (3)

 

270,353

 

 

574,917

Weighted average shares outstanding

 

181,116,674

 

214,910,974

 

153,420,238

 

185,431,404

Net income per common share (1)

$

0.47

$

0.46

$

0.42

$

0.40

(1)Net of preferred stock dividends.
(2)We consider OP Units to be common stock equivalents as the holders have voting rights, the right to distributions and the right to redeem the OP Units for the cash value of a corresponding number of shares of common stock or a corresponding number of shares of common stock, at our election.
(3)Our chief executive officer was granted restricted stock units, which vest at the end of a four-year performance period based upon our achievement of total stockholder return objectives.